Assetmark, Inc Outset Medical, Inc. Transaction History

Assetmark, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$3.07 - $10.25 $5,661 - $18,901	1,844 Added 24.63%	9,331 $50,000
Q3 2023 Oct 27, 2023	BUY	$10.52 - $20.68 $13,413 - $26,367	1,275 Added 20.52%	7,487 $81,000
Q2 2023 Aug 11, 2023	BUY	$17.18 - $23.76 $25,409 - $35,141	1,479 Added 31.25%	6,212 $135,000
Q1 2023 May 05, 2023	BUY	$18.25 - $30.26 $12,081 - $20,032	662 Added 16.26%	4,733 $87,000
Q4 2022 Feb 10, 2023	BUY	$12.36 - $26.41 $16,797 - $35,891	1,359 Added 50.11%	4,071 $105,000

Q3 2022 Nov 01, 2022	BUY	$14.67 - $21.7 $13,203 - $19,530	900 Added 49.67%	2,712 $43,000
Q2 2022 Aug 03, 2022	BUY	$13.46 - $48.16 $19,382 - $69,350	1,440 Added 387.1%	1,812 $27,000
Q1 2022 May 13, 2022	BUY	$34.22 - $47.24 $12,729 - $17,573	372 New	372 $17,000

122

41M

63.4K

32.1K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $184M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.